Evidence map›Paper›PMID 39999661›Full record

ArticleJournal of reproductive immunology2025

Do progesterone receptor membrane components (PGRMC)s play a role in the chorions refractoriness to epithelial-to-mesenchymal transition (EMT)?

B Bush, L S Richardson, E Radnaa, F Behnia, J Jacob, R C V Lintao, R Menon

Abstract read
In one paragraph

Article in Journal of reproductive immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

B BushDivision of Basic Science & Translational Research, Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, TX, USA; Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, TX, USA.
L S RichardsonDivision of Basic Science & Translational Research, Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, TX, USA; Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, TX, USA.
E RadnaaDivision of Basic Science & Translational Research, Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, TX, USA; Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, TX, USA.
F BehniaDepartment of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, TX, USA.
J JacobDivision of Basic Science & Translational Research, Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, TX, USA; Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, TX, USA.
R C V LintaoDivision of Basic Science & Translational Research, Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, TX, USA; Institute of Reproductive Health, National Institutes of Health, University of the c Manila, Philippines.
R MenonDivision of Basic Science & Translational Research, Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, TX, USA; Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, TX, USA. Electronic address: ra2menon@utmb.edu.

Funding

Intercellular interactions define cell migrations and transitions that maintain fetal membrane homeostasisR01HD100729 · NICHD · UNIVERSITY OF TEXAS MED BR GALVESTON · PI HAN, ARUM, MENON, RAMKUMAR · 2020 to 2024
$2.6M
Developing trimester-specific placenta organ-on-chips to model healthy and oxidative stress and inflammation-associated pathologiesR01HD110400 · NICHD · UNIVERSITY OF TEXAS MED BR GALVESTON · PI Lauren Stafford Richardson · 2023 to 2026
$2.3M
3-D biofabricated feto-maternal interface tissue model to determine drug efficacy during pregnancy to reduce the risk of preterm birthUH2TR004117 · NCATS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI HAN, ARUM, MENON, RAMKUMAR · 2022 to 2023
$842k
NCATS NIH HHS UH2 TR004117NICHD NIH HHS R01 HD100729NICHD NIH HHS R01 HD110400
6 · The paper itself

Abstract

Fetal membrane inflammation is one of the drivers of adverse pregnancy outcomes. One of the reported pathways of inflammation is epithelial-mesenchymal transition (EMT) of amniotic epithelial cells. EMT is resisted during gestation via signaling initiated by the binding of progesterone (P4) to progesterone receptor membrane components (PGRMC1/PGRMC2). The vulnerability of chorionic trophoblast cells (CTCs) to transition has not been studied. Here, we examined CTCs EMT in response to the stressors and the role of PGRMC1/PGRMC2. CTCs were treated with the autophagy inhibitor bafilomycin (Baf), transforming growth factor beta (TGF-β, EMT-inducer), and lipopolysaccharide (LPS) to simulate cellular stressors associated with an adverse pregnancy environment. The primary endpoints included morphological evidence of EMT, N-cadherin-to-E-cadherin ratio, vimentin/cytokeratin staining, pro-inflammatory cytokine and P4 production. PGRMC1/PGRMC2 knock-out (KO) CTCs were prepared using CRISPR/Cas9, and experiments were repeated to test the influence of the P4-PGRMC axis. Wild-type CTCs were resistant to cellular transitions, changes in P4 production, and shifts in the inflammatory status under normal, LPS, or TGF-β conditions. Autophagy inhibition tended to cause CTCs to transition (morphological changes; high N-cadherin-to-E-cadherin ratio [p < 0.05], no change in vimentin/cytokeratin), though a complete transition was not evident. Further, neither PGRMC1/PGRMC2 played a role in CTC cellular transitions, as their KO did not cause any major changes. Chorion cells resist EMT to minimize inflammation and to maintain their barrier functions regardless of the presence of PGRMC1/ PGRMC2. Cellular stressors or infectious antigens are likely to impact the amnion, where membrane weakening can be initiated.

Indexed as

Epithelial-Mesenchymal TransitionMembrane ProteinsReceptors, ProgesteroneTrophoblastsAutophagyCells, CulturedFemaleHumansLipopolysaccharidesPregnancyProgesteroneTransforming Growth Factor betaLipopolysaccharidesMembrane ProteinsPGRMC1 protein, humanProgesteroneReceptors, ProgesteroneTransforming Growth Factor betaChorionMembrane ruptureOxidative stressP38 MAPKSenescenceTrophoblast

Identifiers

PMID39999661
PMCPMC12126278

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.